ALNOV:EPA
Novacyt SA
€ 0.44
arrow_downward
-0.11%(-0.00050) Siku 1
30 Okt, 11:50:13 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALNOV...
Fungua
€ 0.44
Juu
€ 0.44
Chini
€ 0.44
Mtaji wa soko
32.16M
Wastani wa kiasi cha mauzo
elfu 195.23
Kiasi cha mauzo ya hisa
elfu 26.91
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.37
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Fungua
€ 0.44
Juu
€ 0.44
Chini
€ 0.44
Mtaji wa soko
32.16M
Wastani wa kiasi cha mauzo
elfu 195.23
Kiasi cha mauzo ya hisa
elfu 26.91
Juu kwa wiki 52
€ 1.04
Chini kwa wiki 52
€ 0.29
EPS
-€ 0.37
Hisa za wawekezaji
72.59M
Idadi ya wafanyakazi
228
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
CNBC
·
dakika 55 zilizopita
Tech scare trade hits Nasdaq futures while crypto reels from its biggest-ever hack
Investor's Business Daily
·
dakika 11 zilizopita
S&P 500: 10 Stocks Turn $100,000 To $25.3 Million In 10 Months
TradingView
·
dakika 32 zilizopita
TNL Mediagene (TNMG) Sells Japan Unit For $5.5M, Says Equity Now Meets Nasdaq Rule
Yahoo Finance
·
dakika 27 zilizopita
Invesco S&P 500 Equal Weight (RSP) Adds Moderna and PTC on Oct. 28
Wasifu
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Kuhusu Novacyt SA
Afisa Mkuu Mtendaji (CEO)David Allmond
Wafanyakazi228
Lilianzishwa3 Jul 2006
Makao makuu-
Sekta-
Tovutinovacyt.com